戻る Agenda
WELCOME AND INTRODUCTION
Session Chair(s)
Dimitri Stamatiadis, PHD, MBA
CEO
Maia Consulting, Switzerland
Hans van Bruggen, MSC
Director of Regulatory Affairs
Celegence, United States
Rejuvenation is about change, renewal, reinventing.Changing our way of working with each other, among industrial competitors, sponsors and regulators, developers and investigators. Renewing the way we use technology, old and new, to unleash our intellectual potential. Reinventing the way we struggle to bring medicines to patients, relief to suffering and ultimately accomplishment for our own selves.
Speaker(s)
Technology- Regulatory Friend or Foe?
Suzanne McDonald
Irish Medicines Board, Ireland
Director-IT and Change Management
The Activities and Vision of TransCelerate
David Evans, MS
CDISC, United States
President & CEO